TTY Biopharm Company Limited 4105.TWO Stock
TTY Biopharm Company Limited Price Chart
TTY Biopharm Company Limited 4105.TWO Financial and Trading Overview
| TTY Biopharm Company Limited stock price | 78.1 TWD |
| Previous Close | 76.2 TWD |
| Open | 76.2 TWD |
| Bid | 76.4 TWD x 0 |
| Ask | 76.7 TWD x 0 |
| Day's Range | 76.2 - 77 TWD |
| 52 Week Range | 68 - 88.5 TWD |
| Volume | 1.29M TWD |
| Avg. Volume | 718.41K TWD |
| Market Cap | 19.02B TWD |
| Beta (5Y Monthly) | 0.313356 |
| PE Ratio (TTM) | 17.168541 |
| EPS (TTM) | 4.53 TWD |
| Forward Dividend & Yield | 3.4 (4.44%) |
| Ex-Dividend Date | March 30, 2023 |
| 1y Target Est | 75 TWD |
4105.TWO Valuation Measures
| Enterprise Value | 18.84B TWD |
| Trailing P/E | 17.168541 |
| Forward P/E | 15.098815 |
| PEG Ratio (5 yr expected) | 1.3 |
| Price/Sales (ttm) | 3.664484 |
| Price/Book (mrq) | 3.7622497 |
| Enterprise Value/Revenue | 3.63 |
| Enterprise Value/EBITDA | 13.341 |
Trading Information
TTY Biopharm Company Limited Stock Price History
| Beta (5Y Monthly) | 0.313356 |
| 52-Week Change | 8.85% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 88.5 TWD |
| 52 Week Low | 68 TWD |
| 50-Day Moving Average | 76.05 TWD |
| 200-Day Moving Average | 76.91 TWD |
4105.TWO Share Statistics
| Avg. Volume (3 month) | 718.41K TWD |
| Avg. Daily Volume (10-Days) | 622.3K TWD |
| Shares Outstanding | 248.65M |
| Float | 192.56M |
| Short Ratio | N/A |
| % Held by Insiders | 20.58% |
| % Held by Institutions | 17.12% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 1.4382001 |
| Last Split Factor | 1067:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 21.29% |
| Operating Margin (ttm) | 23.63% |
| Gross Margin | 59.36% |
| EBITDA Margin | 27.21% |
Management Effectiveness
| Return on Assets (ttm) | 8.14% |
| Return on Equity (ttm) | 19.01% |
Income Statement
| Revenue (ttm) | 5.19B TWD |
| Revenue Per Share (ttm) | 20.91 TWD |
| Quarterly Revenue Growth (yoy) | 12.50% |
| Gross Profit (ttm) | 3.02B TWD |
| EBITDA | 1.41B TWD |
| Net Income Avi to Common (ttm) | 1.11B TWD |
| Diluted EPS (ttm) | 4.45 |
| Quarterly Earnings Growth (yoy) | 4.90% |
Balance Sheet
| Total Cash (mrq) | 2.5B TWD |
| Total Cash Per Share (mrq) | 10.04 TWD |
| Total Debt (mrq) | 1.72B TWD |
| Total Debt/Equity (mrq) | 30.57 TWD |
| Current Ratio (mrq) | 1.413 |
| Book Value Per Share (mrq) | 20.307 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.14B TWD |
| Levered Free Cash Flow (ttm) | 1.29B TWD |
Profile of TTY Biopharm Company Limited
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No.3-1, Park Street |
| ZIP | 11503 |
| Phone | 886 2 2652 5999 |
| Website | https://eng.tty.com.tw |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
TTY Biopharm Company Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally. The company operates through Oncology Business Unit, Health Care Unit, Anti-infection Business Unit, Domestic Cardiovascular and Gastrointestinal Drugs Business Unit, China Medicine Business Unit, and Other segments. It offers oncology drugs under the Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Episil, Otril, Zobonic, Yondelis, Veiasu, and Pemazyre names for anti-cancer and supplementary treatments. The company also provides anti-infection drugs under the Brosym, Colimycin, Cubicin, Lipo-AB, Agrippal, Cepiro, Flusine, Maxtam, Metacin, and Flucelvax names for anti-infection and flu. In addition, it offers healthcare related drugs under the Algitab, Alginos, Alginos Fresh, Bio-Cal Plus, and Sulfin names for digest system, osteoporosis, and metabolism. The company was founded in 1960 and is headquartered in Taipei, Taiwan.
Q&A For TTY Biopharm Company Limited Stock
What is a current 4105.TWO stock price?
TTY Biopharm Company Limited 4105.TWO stock price today per share is 78.1 TWD.
How to purchase TTY Biopharm Company Limited stock?
You can buy 4105.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for TTY Biopharm Company Limited?
The stock symbol or ticker of TTY Biopharm Company Limited is 4105.TWO.
Which industry does the TTY Biopharm Company Limited company belong to?
The TTY Biopharm Company Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does TTY Biopharm Company Limited have in circulation?
The max supply of TTY Biopharm Company Limited shares is 248.65M.
What is TTY Biopharm Company Limited Price to Earnings Ratio (PE Ratio)?
TTY Biopharm Company Limited PE Ratio is 17.24061800 now.
What was TTY Biopharm Company Limited earnings per share over the trailing 12 months (TTM)?
TTY Biopharm Company Limited EPS is 4.53 TWD over the trailing 12 months.
Which sector does the TTY Biopharm Company Limited company belong to?
The TTY Biopharm Company Limited sector is Healthcare.